SMC-116

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSMC-116
Drug Alias NameSMC-116
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosaminoglycan modulators
TargetsGlycosaminoglycan
Therapy Area/IndicationsOsteoarthritisCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSMC Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSMC Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritisCartilage Diseases

Other Information

ATC CodeN/A
Related LinksN/A